Exogenous Flupirtine as Potential Treatment for CLN3 Disease

Exogenous Flupirtine as Potential Treatment for CLN3 Disease

CLN3 disease is a fatal neurodegenerative disorder affecting children. Hallmarks include brain atrophy, accelerated neuronal apoptosis, and ceramide elevation. Treatment regimens are supportive, highlighting the importance of novel, disease-modifying drugs. Flupirtine and its new allyl carbamate der...

Full description

Bibliographic Details
Main Authors:	Katia Maalouf, Joelle Makoukji, Sara Saab, Nadine J. Makhoul, Angelica V. Carmona, Nihar Kinarivala, Noël Ghanem, Paul C. Trippier, Rose-Mary Boustany
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Cells
Subjects:	sphingolipids neurodegeneration ceramide CLN3 disease <i>Cln3<sup>Δex7/8</sup></i> mice flupirtine
Online Access:	https://www.mdpi.com/2073-4409/9/8/1872

Similar Items

Developmental Comparison of Ceramide in Wild-Type and Cln3Δex7/8 Mouse Brains and Sera
by: Sally El-Sitt, et al.
Published: (2019-02-01)

Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype
by: Chiara Soldati, et al.
Published: (2021-10-01)

in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels
by: Alamin Mohammed, et al.
Published: (2017-07-01)

Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender
by: Attila D. Kovács, et al.
Published: (2015-04-01)

Recent Insights into NCL Protein Function Using the Model Organism <i>Dictyostelium discoideum</i>
by: Meagan D. McLaren, et al.
Published: (2019-02-01)

“Atypical” Phenotypes of Neuronal Ceroid Lipofuscinosis: The Argentine Experience in the Genomic Era
by: Favio Pesaola, et al.
Published: (2021-05-01)

The CLN3 gene and protein: What we know
by: Myriam Mirza, et al.
Published: (2019-12-01)

Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinoses
by: John R. Ostergaard, et al.
Published: (2022-11-01)

Phenotypic variant of CLN3 mutation
by: Avinash Honasoge, et al.
Published: (2022-09-01)

<i>CLN8</i> Gene Compound Heterozygous Variants: A New Case and Protein Bioinformatics Analyses
by: Rajech Sharkia, et al.
Published: (2022-08-01)

Identification of a novel mutation of rare CLN6 case and computation protein structure
by: Fozhan Saboori, et al.
Published: (2023-10-01)

<i>CLN8</i> Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis—Literature Review and Case Report
by: Magdalena Badura-Stronka, et al.
Published: (2021-06-01)

Role of Cln1 during melanization of Cryptococcus neoformans
by: Rocío eGarcía-Rodas, et al.
Published: (2015-08-01)

A novel candidate gene CLN8 regulates fat deposition in avian
by: Xiaoqin Li, et al.
Published: (2023-05-01)

Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in Cln3−/− Mice
by: Marta A. Tarczyluk-Wells, et al.
Published: (2019-09-01)

Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis
by: Xiao-Tun Ren, et al.
Published: (2019-04-01)

The c.1A > C start codon mutation in CLN3 is associated with a protracted disease course
by: Willemijn F. E. Kuper, et al.
Published: (2020-03-01)

Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease
by: Elena K. Shematorova, et al.
Published: (2020-10-01)

Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)
by: Maria Burkovetskaya, et al.
Published: (2017-04-01)

Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants
by: Zhijie Gao, et al.
Published: (2018-02-01)

Comparison of analgesic efficacy of flupirtine maleate and ibuprofen in gynaecological ambulatory surgeries: A randomized controlled trial
by: Vanita Ahuja, et al.
Published: (2015-01-01)

Regulation of the <named-content content-type="genus-species">Candida albicans</named-content> Hypha-Inducing Transcription Factor Ume6 by the CDK1 Cyclins Cln3 and Hgc1
by: Sigal Mendelsohn, et al.
Published: (2017-04-01)

Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)
by: Paul Gissen, et al.
Published: (2021-05-01)

A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures
by: Song-Lin Ding, et al.
Published: (2011-02-01)

Gene correction of the CLN3 c.175G>A variant in patient‐derived induced pluripotent stem cells prevents pathological changes in retinal organoids
by: Xiao Zhang, et al.
Published: (2021-03-01)

Lysosomal Proteomics Links Disturbances in Lipid Homeostasis and Sphingolipid Metabolism to CLN5 Disease
by: Stefano Doccini, et al.
Published: (2022-06-01)

Flupirtine : Clinical pharmacology
by: S Harish, et al.
Published: (2012-01-01)

Etiology of anxious and fearful behavior in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)
by: John R. Ostergaard
Published: (2023-04-01)

Randomized controlled trial about pain medication flupirtine ignores recent pharmacovigilance warnings
by: Puljak L
Published: (2018-01-01)

A comparative study of efficacy and safety of flupirtine versus piroxicam in postoperative pain in patients undergoing lower limb surgery
by: Chinnaiyan S, et al.
Published: (2017-10-01)

Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats
by: Madhoosudan A. Patil, et al.
Published: (2018-12-01)

Deficiency of the Lysosomal Protein CLN5 Alters Lysosomal Function and Movement
by: Indranil Basak, et al.
Published: (2021-09-01)

Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis
by: Katja M. Kanninen, et al.
Published: (2013-05-01)

Aberrant Autophagy Impacts Growth and Multicellular Development in a Dictyostelium Knockout Model of CLN5 Disease
by: Meagan D. McLaren, et al.
Published: (2021-07-01)

Efficacy of flupirtine for postoperative pain: A systematic review and meta-analysis
by: Samarjit Dey, et al.
Published: (2023-01-01)

Advancing Forensic Chemical Analysis to Classify Wild and Captive Turtles
by: John B. Hopkins, et al.
Published: (2023-09-01)

Moyamoya and progressive myoclonic epilepsy secondary to CLN6 bi-allelic mutations – A previously unreported association
by: Jamie Talbot, et al.
Published: (2020-01-01)

The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease
by: Juan Yang, et al.
Published: (2021-10-01)

The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain
by: Ville Holmberg, et al.
Published: (2004-06-01)

Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice
by: Katherine A. White, et al.
Published: (2021-03-01)